Lloyd Advisory Services’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,381
Closed -$332K 778
2026
Q1
$332K Buy
2,381
+1,782
+297% +$250K 0.1% 104
2025
Q4
$73.5K Buy
+599
New +$72.8K 0.03% 209
2025
Q2
Sell
-1,902
Closed -$213K 107
2025
Q1
$213K Sell
1,902
-512
-21% -$52.8K 0.11% 96
2024
Q4
$223K Sell
2,414
-598
-20% -$53.8K 0.11% 89
2024
Q3
$252K Sell
3,012
-464
-13% -$35.4K 0.12% 84
2024
Q2
$238K Buy
+3,476
New +$232K 0.11% 82
2024
Q1
Sell
-2,612
Closed -$212K 143
2023
Q4
$212K Sell
2,612
-5,374
-67% -$418K 0.1% 122
2023
Q3
$598K Buy
+7,986
New +$614K 0.2% 118
2022
Q2
Sell
-3,686
Closed -$219K 255
2022
Q1
$219K Buy
3,686
+590
+19% +$37.7K 0.1% 87
2021
Q4
$225K Sell
3,096
-20
-0.6% -$1.38K 0.1% 73
2021
Q3
$218K Sell
3,116
-74
-2% -$5.2K 0.11% 70
2021
Q2
$220K Sell
3,190
-2
-0.1% -$134 0.11% 72
2021
Q1
$206K Sell
3,192
-156
-5% -$10.1K 0.11% 60
2020
Q4
$195K Buy
3,348
+537
+19% +$32.4K 0.11% 52
2020
Q3
$178K Buy
2,811
+1,610
+134% +$112K 0.11% 51
2020
Q2
$92K Sell
1,201
-2,520
-68% -$193K 0.06% 83
2020
Q1
$278K Sell
3,721
-24
-0.6% -$1.66K 0.21% 37
2019
Q4
$243K Buy
+3,745
New +$244K 0.22% 62

Other funds holding GILD

Lloyd Advisory Services's GILD Position: Q2 2026 in Review

Lloyd Advisory Services sold out of Gilead Sciences (GILD) in Q2 2026, closing a stake of 2,381 shares — an estimated $332K sold.

Lloyd Advisory Services first reported a position in GILD in Q4 2019 and held it in 18 quarters. The position peaked at $598K in Q3 2023. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Lloyd Advisory Services reported no remaining Gilead Sciences position as of Q2 2026 after selling out during the quarter.
  • Lloyd Advisory Services sold 2,381 Gilead Sciences shares in Q2 2026, an estimated $332K.
  • Lloyd Advisory Services first reported a position in Gilead Sciences in Q4 2019 and held it in 18 quarters.
  • Lloyd Advisory Services's Gilead Sciences position peaked at $598K in Q3 2023.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Lloyd Advisory Services's 13F filing for Q2 2026, filed 7 Aug 2026.